Importantly, and thereby highlighting a key role for adiponectin in NAFLD, it could be recently demonstrated that lean NAFLD patients show reduced circulating adiponectin concentrations [40]. The gene discussed is ADIPOQ; the disease is metabolic dysfunction-associated steatotic liver disease.